Cedric Francois Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week ago
Cedric Francois has an estimated net worth of at least $59.8 million*, as of Dec. 18, 2024. They own 785,727 shares of APLS stock. They have sold 551,287 shares of APLS stock since 2021, for an estimated $32.8 million.
Cedric Francois $APLS SEC Form 4 Insider Trading
Cedric Francois has filed a total of 22 insider trades in $APLS since 2021. Their most recent trade was a sale of 413 shares, made on Mar 01, 2024. Their largest trade was a sale of 139,716 shares, made on Sep 01, 2023. We estimate that they now own 785,727 shares of $APLS, worth an estimated $27.0 million.
Insider Trading at $APLS
There have been a total of 247 insider trades reported at $APLS since 2021, with 250,000 shares purchased and 1.9 million shares sold. The most active insider traders in $APLS stock have been Pascal Deschatelets, Cedric Francois, and Federico Grossi. The most recent trade was a sale of 5,000 shares reported by David O. Watson (General Counsel), made on Dec 11, 2024.
History of Insider Stock Trades by Cedric Francois
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
APLS | Sale | 413 | Mar 01, 2024 | March 5, 2024, 5:07 p.m. |
APLS | Sale | 116,512 | Mar 01, 2024 | March 5, 2024, 5:07 p.m. |
APLS | Sale | 62,503 | Mar 01, 2024 | March 5, 2024, 5:07 p.m. |
APLS | Sale | 41,704 | Mar 01, 2024 | March 5, 2024, 5:07 p.m. |
APLS | Sale | 28,868 | Mar 01, 2024 | March 5, 2024, 5:07 p.m. |
APLS | Sale | 3,962 | Feb 12, 2024 | Feb. 13, 2024, 5:49 p.m. |
APLS | Sale | 2,843 | Jan 29, 2024 | Jan. 31, 2024, 5:26 p.m. |
APLS | Sale | 13,431 | Jan 22, 2024 | Jan. 23, 2024, 8:28 p.m. |
APLS | Sale | 7,851 | Jan 16, 2024 | Jan. 17, 2024, 5:32 p.m. |
APLS | Sale | 5,000 | Nov 21, 2023 | Nov. 21, 2023, 6:36 p.m. |
APLS | Sale | 10,284 | Sep 01, 2023 | Sept. 1, 2023, 4:05 p.m. |
APLS | Sale | 139,716 | Sep 01, 2023 | Sept. 1, 2023, 4:05 p.m. |
APLS | Sale | 934 | May 16, 2023 | May 18, 2023, 5:10 p.m. |
APLS | Sale | 2,120 | May 16, 2023 | May 18, 2023, 5:10 p.m. |
APLS | Sale | 7,528 | May 16, 2023 | May 18, 2023, 5:10 p.m. |
APLS | Sale | 3,007 | May 16, 2023 | May 18, 2023, 5:10 p.m. |
APLS | Sale | 14,611 | May 16, 2023 | May 18, 2023, 5:10 p.m. |
APLS | Sale | 1,800 | May 16, 2023 | May 18, 2023, 5:10 p.m. |
APLS | Sale | 30,000 | Apr 18, 2023 | April 20, 2023, 4:51 p.m. |
APLS | Sale | 30,000 | Mar 21, 2023 | March 23, 2023, 4:55 p.m. |
APLS | Sale | 24,449 | Dec 19, 2022 | Dec. 21, 2022, 5:13 p.m. |
APLS | Sale | 3,751 | Dec 19, 2022 | Dec. 21, 2022, 5:13 p.m. |
$APLS Executives and Stock Owners with Insider Trades
-
Pascal Deschatelets, Chief Scientific Officer
-
Cedric Francois, Chief Executive Officer
-
Federico Grossi, CHIEF MEDICAL OFFICER
-
Adam J. Townsend, Chief Commercial Officer
-
David O. Watson, General Counsel
-
Timothy Eugene Sullivan, Chief Financial Officer
-
Karen Lewis, Chief People Officer
-
Mark Jeffrey Delong, Senior Vice President
-
Lukas Scheibler, CHIEF INNOVATION OFFICER
-
Jeffrey Eisele, Chief Development Officer
-
Nur Nicholson, Chief Technical Officer
-
James George Chopas, VP/Chief Accounting Officer
-
Mark Jeffrey Delong, Chief Business & Strat Officer
-
Nicole D Perry, Vice President - Accounting
-
Federico Grossi, Chief Medical Officer
-
Lukas Scheibler, Chief Research Officer
-
Caroline Baumal, Chief Medical Officer
-
Victoria L. Brown, Program Team Lead
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.